Back
Brookfield Vs. Xtacy Therapeutics Industry Stock Comparison
Buy
81
BN.TO
Brookfield
Last Price:
60.27
Seasonality Move:
2.04%
Sell
25
XTCY.CX
Xtacy Therapeutics
Last Price:
0.03
Seasonality Move:
-11.71%
Buy
81
Brookfield (BN.TO)
is a Buy
Is Brookfield a Buy, Sell or Hold?
- The current Brookfield [BN.TO] share price is $60.49. The Score for BN.TO is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
- BN.TO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
25
Xtacy Therapeutics (XTCY.CX)
is a Sell
Is Xtacy Therapeutics a Buy, Sell or Hold?
- The current Xtacy Therapeutics [XTCY.CX] share price is $0.03. The Score for XTCY.CX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- XTCY.CX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BN.TO Stock Price Chart
What is Brookfield's stock price today?
-
The Brookfield share price today is $60.49
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BN.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.
XTCY.CX Stock Price Chart
What is Xtacy Therapeutics's stock price today?
-
The Xtacy Therapeutics share price today is $0.03
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTCY.CX is experiencing slight buying pressure.
BN.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.31 | Buy |
| Relative Strength Index (14 RSI): | 73.32 | Buy |
| Chaikin Money Flow: | 2004585 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.55 - 58.03) | Buy |
| Bollinger Bands (100): | (52.75 - 56.65) | Buy |
XTCY.CX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 42.16 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.03 - 0.05) | Sell |
| Bollinger Bands (100): | (0.03 - 0.07) | Sell |
BN.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.44 | Buy |
| 20-day SMA: | 56.07 | Buy |
| 50-day SMA: | 55.95 | Buy |
| 200-day SMA: | 50.01 | Buy |
| 8-day EMA: | 58.82 | Buy |
| 20-day EMA: | 57.1 | Buy |
| 50-day EMA: | 55.82 | Buy |
| 200-day EMA: | 51.52 | Buy |
XTCY.CX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.04 | Sell |
| 20-day SMA: | 0.04 | Sell |
| 50-day SMA: | 0.05 | Sell |
| 200-day SMA: | 0.05 | Sell |
| 8-day EMA: | 0.03 | Sell |
| 20-day EMA: | 0.04 | Sell |
| 50-day EMA: | 0.04 | Sell |
| 200-day EMA: | 0.06 | Sell |
Brookfield Earnings Growth & BN.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.74 per share, and an increase next year of $1.52 per share.
Xtacy Therapeutics Earnings Growth & XTCY.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Brookfield Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Xtacy Therapeutics Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||